Latest Spasmodic torticollis Stories

2011-12-23 17:10:00

Dr. Ingrid Warmuth is a specialist in many areas of dermatology and has been voted "Best Of The Best" by readers of the Vineland Daily Journal, and voted “Top Doc in South Jersey”. Elmer, New Jersey (PRWEB) December 23, 2011 Dr. Ingrid Warmuth is one of the selected providers for the early release of Xeomin. The Food and Drug Administration (FDA) recently approved this new botulinum toxin type A in July, 2011 for aesthetic indication; particularly to treat moderate to severe...

2011-08-25 09:27:14

  The US Food and Drug Administration (FDA) has given approval for Allergan, the maker of Botox, to market the drug to treat a specific kind of overactive bladder condition, Reuters is reporting. After receiving similar approval in Europe earlier this month, US regulators are allowing Botox to be injected into the bladder to treat those who lose bladder control because of damage to the nervous system through conditions such as multiple sclerosis or spinal cord injury. Botox´...

2011-06-08 12:30:00

FRANKFURT, Germany, June 8, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced that new data on Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory (complexing) proteins, will be presented at the Movement Disorder Society's (MDS) 15th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada. The studies found that repeated injections of XEOMIN were safe and effective in the treatment of blepharospasm and...

2011-05-07 00:00:29

Noel Valero, founder of the American Dystonia Society (ADS), has carved out a section of its website for its members to ask questions of Social Security disability representative Frederick Johnson. The section has been dubbed "Ask Fred About SSDI." Pooler, GA (PRWEB) May 06, 2011 Frederick Johnson, a Social Security disability representative and president of Disability Income Associates, LLC, with 21 years of experience in helping over 1,000 patients get Social Security disability...

2011-04-14 07:11:00

GREENSBORO, N.C., April 14, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC, maker of XEOMIN® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, today announced the launch of the "Make Your Mark" campaign. With the help of patient advocates, "Make Your Mark" celebrates the inspirational stories of people living with blepharospasm or cervical dystonia (CD), also known as spasmodic torticollis, and aims to raise awareness of these often...

2011-04-12 08:00:00

FRANKFURT, Germany, April 12, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced that results from sub-group analyses of a prospective, repeated dose, double-blind study evaluating the long-term safety and efficacy of XEOMIN® (incobotulinumtoxinA), a botulinum toxin type A free from accessory (complexing) proteins, will be presented at the 63rd Annual Meeting of the American Academy of Neurology (AAN) in Honolulu, Hawaii, U.S. The data show that repeated injections...

Word of the Day
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.